HTA of MDs
Health Technology Assessment of Medical Devices

HTA is multi-disciplinary field of policy analysis that examines the medical, economic, social and ethical implications of the incremental value, diffusion and use of a health technology in health care.

The term Health Technology refers to application of organised knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of life.

Library of Assessments on MDs (1999-2020)

5 Entries tagged with "diabetes"

Show all

Fibreglass Total Contact Casting, Removable Cast Walkers, and Irremovable Cast Walkers to Treat Diabetic Neuropathic Foot Ulcers: A Health Technology Assessment

Original Summary: About 1 in 10 people in Ontario have diabetes. Each year, about 2% to 3% of them develop a foot ulcer. Diabetic foot ulcers put people at risk for foot and lower leg amputation. Pressure offloading devices, which include fibreglass total contact casting, removable cast walkers, and irremovable cast walkers, are used to treat […]

Duodenal-jejunal bypass sleeve for the treatment of obesity with or without Type 2 Diabetes

This assessment addresses two subpopulations of interest:  1) adult obese patients (grade III obesity/BMI ≥40 or grade II obesity/BMI 35.0–39.9 with comorbidities)  2) patients with Type 2 DM and obesity ≥ grade I.  The DJBS is a 60 cm long impermeable sleeve-like device (fluoropolymer), placed endo-scopically under general anaesthesia into the small intestine for up to […]

HTA report: new devices for the management of glycaemia in young diabetics

The report is developed to answer the question: “Are there economically sustainable new devices to enhance the management of diabetes type I in people aged 0-18 and do they provide better health and quality of life to patients and carers?” The topic of the report is Sensor augmented insulin pump (or SAP for short) which is […]

Insulin pump therapy for type 1 diabetes

The Alberta Health and Wellness’ Executive Committee accepted the Alberta Health Technology Decision Program’s Advisory Committee’s recommendation to undertake a STE analysis of insulin delivery systems. The purpose of this report is to address the following questions of interest: What is the potential role of insulin pump therapy (IPT) in the intensive treatment of Albertans with type 1 diabetes […]

Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations

In June 2008, the Medical Advisory Secretariat began work on the Diabetes Strategy Evidence Project, an evidence-based review of the literature surrounding strategies for successful management and treatment of diabetes. This project came about when the Health System Strategy Division at the Ministry of Health and Long-Term Care subsequently asked the secretariat to provide an evidentiary […]